MedTrace Logo

Multimodal Preventive Trial for Alzheimer's Disease

NCT03249688 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 93

Last updated 2021-09-23

No results posted yet for this study

Summary

The main aim of the MIND-ADmini pilot trial is to evaluate the feasibility of a multimodal lifestyle intervention among patients with prodromal AD.

Conditions

  • Alzheimer Disease; Prodromal

Interventions

OTHER

Regular health advice

Routine healthy lifestyle counseling

BEHAVIORAL

Multidomain lifestyle

Nutritional guidance, exercise, cognitive training, vascular risk monitoring

DIETARY_SUPPLEMENT

Medical food

Medical food product (Fortasyn Connect)

Sponsors & Collaborators

  • University of Eastern Finland

    collaborator OTHER

  • Universität des Saarlandes

    collaborator OTHER

  • University Hospital, Toulouse

    collaborator OTHER

  • Karolinska Institutet

    lead OTHER

Principal Investigators

  • Miia Kivipelto, MD, PhD · Karolinska Institutet

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-16
Primary Completion
2019-12-23
Completion
2020-12-18

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03249688 on ClinicalTrials.gov